A CXCR1/CXCR2 and heterologous GPCR antagonism in melanoma development
Being the most aggressive human skin cancers, melanoma has always occurred with a poor prognosis. It is responsible for 80% of skin cancer. Treatments for melanoma include surgical removal, and radio- and chemotherapy, which are not effective toward the advanced stages of the disease. Only three...
Other Authors: | Gordon, John R. |
---|---|
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/10388/ETD-2015-05-2089 |
Similar Items
-
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
by: Hara Takahiko, et al.
Published: (2014-05-01) -
The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell Function
by: Ruth M. Urbantat, et al.
Published: (2021-03-01) -
Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
by: Ala Litman-Zawadzka, et al.
Published: (2020-08-01) -
CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
by: Fedora Grande, et al.
Published: (2019-02-01) -
The sequelae of CXCR4 engagement
by: Murphy, Brendan John
Published: (2001)